Literature DB >> 29738845

MicroRNA-7 facilitates the degradation of alpha-synuclein and its aggregates by promoting autophagy.

Doo Chul Choi1, Myungsik Yoo1, Savan Kabaria1, Eunsung Junn2.   

Abstract

Alpha-Synuclein (α-Syn) is an important protein in the pathogenesis of Parkinson disease (PD) as it accumulates as fibrillar inclusions in affected brain regions including dopaminergic neurons in the substantia nigra. Elevated levels of α-Syn seem to be crucial in mediating its toxicity. Thus, detailed information regarding the regulatory mechanism of α-Syn expression in several layers such as transcription, post-transcription and post-translation is needed in order to devise therapeutic interventions for PD. Previously, we reported that expression of α-Syn is repressed by microRNA-7 (miR-7) through its effect on the 3'-untranslated region (UTR) of α-Syn mRNA. Here, we show that miR-7 also accelerates the clearance of α-Syn and its aggregates by promoting autophagy in differentiated ReNcell VM cells. Further, miR-7 facilitates the degradation of pre-formed fibrils of α-Syn transported from outside the cells. This additional mechanism for reducing α-Syn levels show miR-7 to be an important molecular target for PD and other alpha-synucleinopathies.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Alpha-Synuclein; Autophagy; MicroRNA-7; Parkinson disease

Mesh:

Substances:

Year:  2018        PMID: 29738845      PMCID: PMC5990033          DOI: 10.1016/j.neulet.2018.05.009

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  33 in total

Review 1.  MicroRNAs: small RNAs with a big role in gene regulation.

Authors:  Lin He; Gregory J Hannon
Journal:  Nat Rev Genet       Date:  2004-07       Impact factor: 53.242

Review 2.  Parkinson's disease.

Authors:  Bobby Thomas; M Flint Beal
Journal:  Hum Mol Genet       Date:  2007-10-15       Impact factor: 6.150

Review 3.  Recent advances in the genetics and pathogenesis of Parkinson disease.

Authors:  M Maral Mouradian
Journal:  Neurology       Date:  2002-01-22       Impact factor: 9.910

4.  Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease.

Authors:  R Krüger; W Kuhn; T Müller; D Woitalla; M Graeber; S Kösel; H Przuntek; J T Epplen; L Schöls; O Riess
Journal:  Nat Genet       Date:  1998-02       Impact factor: 38.330

5.  MicroRNA-7 Promotes Glycolysis to Protect against 1-Methyl-4-phenylpyridinium-induced Cell Death.

Authors:  Amrita Datta Chaudhuri; Savan Kabaria; Doo Chul Choi; M Maral Mouradian; Eunsung Junn
Journal:  J Biol Chem       Date:  2015-03-26       Impact factor: 5.157

6.  Collaborative analysis of alpha-synuclein gene promoter variability and Parkinson disease.

Authors:  Demetrius M Maraganore; Mariza de Andrade; Alexis Elbaz; Matthew J Farrer; John P Ioannidis; Rejko Krüger; Walter A Rocca; Nicole K Schneider; Timothy G Lesnick; Sarah J Lincoln; Mary M Hulihan; Jan O Aasly; Tetsuo Ashizawa; Marie-Christine Chartier-Harlin; Harvey Checkoway; Carlo Ferrarese; Georgios Hadjigeorgiou; Nobutaka Hattori; Hideshi Kawakami; Jean-Charles Lambert; Timothy Lynch; George D Mellick; Spiridon Papapetropoulos; Abbas Parsian; Aldo Quattrone; Olaf Riess; Eng-King Tan; Christine Van Broeckhoven
Journal:  JAMA       Date:  2006-08-09       Impact factor: 56.272

7.  Alternative α-synuclein transcript usage as a convergent mechanism in Parkinson's disease pathology.

Authors:  Herve Rhinn; Liang Qiang; Toru Yamashita; David Rhee; Ari Zolin; William Vanti; Asa Abeliovich
Journal:  Nat Commun       Date:  2012       Impact factor: 14.919

8.  Parkinson disease, LRRK2 and the endocytic-autophagic pathway.

Authors:  Javier Alegre-Abarrategui; Richard Wade-Martins
Journal:  Autophagy       Date:  2009-11-24       Impact factor: 16.016

Review 9.  Therapeutic potential of autophagy-enhancing agents in Parkinson's disease.

Authors:  Tim E Moors; Jeroen J M Hoozemans; Angela Ingrassia; Tommaso Beccari; Lucilla Parnetti; Marie-Christine Chartier-Harlin; Wilma D J van de Berg
Journal:  Mol Neurodegener       Date:  2017-01-25       Impact factor: 14.195

10.  Nilotinib Effects in Parkinson's disease and Dementia with Lewy bodies.

Authors:  Fernando Pagan; Michaeline Hebron; Ellen H Valadez; Yasar Torres-Yaghi; Xu Huang; Reversa R Mills; Barbara M Wilmarth; Hellen Howard; Connell Dunn; Alexis Carlson; Abigail Lawler; Sean L Rogers; Ramsey A Falconer; Jaeil Ahn; Zhaoxia Li; Charbel Moussa
Journal:  J Parkinsons Dis       Date:  2016-07-11       Impact factor: 5.568

View more
  13 in total

Review 1.  Nucleic Acid-Based Therapeutics for Parkinson's Disease.

Authors:  Masayuki Nakamori; Eunsung Junn; Hideki Mochizuki; M Maral Mouradian
Journal:  Neurotherapeutics       Date:  2019-04       Impact factor: 7.620

2.  MicroRNA miR-7 Is Essential for Post-stroke Functional Recovery.

Authors:  Suresh L Mehta; Anil K Chokkalla; Saivenkateshkomal Bathula; Raghu Vemuganti
Journal:  Transl Stroke Res       Date:  2022-01-28       Impact factor: 6.800

Review 3.  The role of microRNAs in diseases and related signaling pathways.

Authors:  Atena Vaghf; Behzad Khansarinejad; Ehsanollah Ghaznavi-Rad; Mahdieh Mondanizadeh
Journal:  Mol Biol Rep       Date:  2021-10-31       Impact factor: 2.742

Review 4.  Context-Dependent Regulation of Gene Expression by Non-Canonical Small RNAs.

Authors:  Kinga Plawgo; Katarzyna Dorota Raczynska
Journal:  Noncoding RNA       Date:  2022-04-29

5.  MicroRNA-7 Protects Against Neurodegeneration Induced by α-Synuclein Preformed Fibrils in the Mouse Brain.

Authors:  Jie Zhang; Mengyuan Zhao; Run Yan; Jun Liu; Santhosh Maddila; Eunsung Junn; M Maral Mouradian
Journal:  Neurotherapeutics       Date:  2021-10-25       Impact factor: 6.088

Review 6.  MicroRNAs: Game Changers in the Regulation of α-Synuclein in Parkinson's Disease.

Authors:  Liang Zhao; Zhiqin Wang
Journal:  Parkinsons Dis       Date:  2019-05-02

Review 7.  MicroRNA-7: expression and function in brain physiological and pathological processes.

Authors:  Juanjuan Zhao; Ya Zhou; Mengmeng Guo; Dongxu Yue; Chao Chen; Guiyou Liang; Lin Xu
Journal:  Cell Biosci       Date:  2020-06-10       Impact factor: 7.133

Review 8.  Non-Coding RNAs in the Brain-Heart Axis: The Case of Parkinson's Disease.

Authors:  Shubhra Acharya; Antonio Salgado-Somoza; Francesca Maria Stefanizzi; Andrew I Lumley; Lu Zhang; Enrico Glaab; Patrick May; Yvan Devaux
Journal:  Int J Mol Sci       Date:  2020-09-06       Impact factor: 5.923

Review 9.  Does the Expression and Epigenetics of Genes Involved in Monogenic Forms of Parkinson's Disease Influence Sporadic Forms?

Authors:  Aymeric Lanore; Suzanne Lesage; Louise-Laure Mariani; Poornima Jayadev Menon; Philippe Ravassard; Helene Cheval; Olga Corti; Alexis Brice; Jean-Christophe Corvol
Journal:  Genes (Basel)       Date:  2022-03-08       Impact factor: 4.096

Review 10.  Roles of Non-Coding RNAs as Novel Diagnostic Biomarkers in Parkinson's Disease.

Authors:  Ida Manna; Andrea Quattrone; Selene De Benedittis; Enrico Iaccino; Aldo Quattrone
Journal:  J Parkinsons Dis       Date:  2021       Impact factor: 5.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.